¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hyper"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • hyperreninemia
    °ú·¹´ÑÇ÷Áõ
  • hyperresonance
    °ú´Ù°ø¸í
  • hypersalivation
    °ú´ÙħºÐºñ
  • hypersecretion
    °ú´ÙºÐºñ
  • hypersecretion glaucoma
    °ú´ÙºÐºñ³ì³»Àå
  • hypersecretory gastropathy
    °ú´ÙºÐºñÀ§º´Áõ
  • hypersegmentation
    °ú´ÙºÐÀý(Áõ)
  • hypersegmented neutrophil
    °ú´ÙºÐ¿±ÇÙÁß¼º±¸
  • hypersensitive
    °ú¹Î-
  • hypersensitiveness
    °ú¹ÎÁõ
  • hypersensitivity
    1. °ú¹Î(¼º) 2. °ú¹Î(Áõ)
  • hypersensitivity angitis
    °ú¹Î¸Æ°ü¿°
  • hypersensitivity disorder
    °ú¹ÎÁúȯ
  • hypersensitivity myocarditis
    °ú¹Î½É±Ù¿°
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • hypersalivation
    °ú´ÙħºÐºñ
  • hypersecretion
    °ú´ÙºÐºñ
  • hypersecretion glaucoma
    °ú´ÙºÐºñ³ì³»Àå
  • hypersecretory gastropathy
    °ú´ÙºÐºñÀ§º´Áõ
  • hypersegmentation
    °ú´ÙºÐȹ
  • hypersegmented neutrophil
    °ú´ÙºÐȹȣÁß±¸
  • hypersensitive
    °ú¹Î-
  • hypersensitive carotid sinus
    °ú¹Î¸ñµ¿¸Æ±¼
  • hypersensitive vasculitis
    °ú¹ÎÇ÷°ü¿°
  • hypersensitiveness
    °ú¹Î¼º, °ú¹ÎÁõ
  • hypersensitivity
    °ú¹Î
  • hypersensitivity angitis
    °ú¹Î¸Æ°ü¿°
  • hypersensitivity disorder
    °ú¹ÎÁúȯ
  • hypersensitivity myocarditis
    °ú¹Î½É±Ù¿°
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • hyperlipidemia
    °íÁöÇ÷Áõ
  • hyperlipidemia
    °íÁöÇ÷Áõ(˭̴̡̤).
  • hyperlipidemia
    °úÁöÇ÷Áõ(Φò·úìñø).
  • hyperlipidemia
    °íÁöÇ÷Áõ(ÍÔò·úìñø)
  • hyperlipidemia
    °íÁöÇ÷Áõ(ÍÔò·úìñø).
  • hyperlipoidemia
    À¯ÁöÁú°úÀ×Ç÷(Áõ)(×¾ò·òõΦ í¥úìñø).
  • hyperlipoproteinemia
    °úÁö¹æ´Ü¹éÇ÷Áõ, °íÁö¹æ´Ü¹éÇ÷Áõ
  • hyperlipoproteinemia
    °íÁö´Ü¹éÇ÷Áõ
  • hyperlipoproteinemia
    °úÁö´Ü¹éÇ÷Áõ.
  • hyperlipoproteinemia
    °íÁö´Ü¹éÇ÷Áõ(ÍÔò·Ó±ÛÜúìñø)
  • hyperlipoproteinemia
    °íÁö´Ü¹éÇ÷Áõ.
  • hyperlipoproteinemia pancreatitis
    °úÁö¹æ´Ü¹éÇ÷ÁõÃé(Àå)¿°
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
  • hyperlipoproteinemia type IV
    °í´Ü¹éÇ÷Áõ IV Çü
  • hyperlipoprotenemia type II
    °íÁö´Ü¹éÇ÷Áõ II Çü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
  • hyperleukocystitos
  • hyperlipidemia
    °úÁö¹æÇ÷Áõ, °íÁö¹æÇ÷Áõ
  • hyperlipidemia
    °íÁöÇ÷Áõ
  • hyperlipidemia
    °íÁöÇ÷Áõ(˭̴̡̤).
  • hyperlipidemia
    °úÁöÇ÷Áõ(Φò·úìñø).
  • hyperlipidemia
    °íÁöÇ÷Áõ(ÍÔò·úìñø)
  • hyperlipidemia
    °íÁöÇ÷Áõ(ÍÔò·úìñø).
  • hyperlipoidemia
    À¯ÁöÁú°úÀ×Ç÷(Áõ)(×¾ò·òõΦ í¥úìñø).
  • hyperlipoproteinemia
    °úÁö¹æ´Ü¹éÇ÷Áõ, °íÁö¹æ´Ü¹éÇ÷Áõ
  • hyperlipoproteinemia
    °íÁö´Ü¹éÇ÷Áõ
  • hyperlipoproteinemia
    °úÁö´Ü¹éÇ÷Áõ.
  • hyperlipoproteinemia
    °íÁö´Ü¹éÇ÷Áõ(ÍÔò·Ó±ÛÜúìñø)
  • hyperlipoproteinemia
    °íÁö´Ü¹éÇ÷Áõ.
  • hyperlipoproteinemia pancreatitis
    °úÁö¹æ´Ü¹éÇ÷ÁõÃé(Àå)¿°
  • hyperlipoproteinemia type III
    °íÁö´Ü¹éÇ÷Áõ III
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 17
hyperlactation The continuance of lactation beyond the normal period.
Synonym: hyperlactation.
(05 Mar 2000)
hyperleukocytosis An unusually great increase in the number and proportion of leukocytes in the circulating blood or the tissues; i.e., much more than that ordinarily observed in most instances of leukocytosis.
(05 Mar 2000)
hyperlexia In retarded children, the presence of relatively advanced reading ability.
Origin: hyper-+ G. Lexis, word, phrase
(05 Mar 2000)
hyperlipaemia <biochemistry> Increased fats in the bloodstream. One can see the fat globules in blood specimens which are particularly high in fats with the naked eye.
Origin: Gr. Haima = blood
(27 Sep 1997)
hyperlipidaemia <biochemistry> A general term for elevated concentrations of any or all of the lipids in the plasma, such as cholesterol, triglycerides and lipoproteins.
Origin: Gr. Haima = blood
(18 Nov 1997)
hyperlipidemia <biochemistry> A general term for elevated concentrations of any or all of the lipids in the plasma, such as cholesterol, triglycerides and lipoproteins.
Origin: Gr. Haima = blood
(18 Nov 1997)
hyperlipidemia, familial combined A disorder genetically distinct from the other inherited hyperlipidemias characterised by the type II or type IV lipoprotein pattern (the pattern may change from time to time and the lipid level may be normal at one time and abnormal at another time).
(12 Dec 1998)
hyperlipoidemia <biochemistry> Presence of an abnormally high amount of lipid in the bloodstream.
Origin: Gr. Haima = blood
(18 Nov 1997)
hyperlipoproteinaemia <biochemistry> The same as hyperlipidaemia.
(18 Nov 1997)
hyperlipoproteinaemia type III A rather uncommon form of familial hyperlipaemia characterised by the presence of lipoproteins of abnormal composition. The main abnormal lipoproteins are called beta-vldl and have a different apoprotein content and a higher proportion of cholesterol relative to triglyceride than normal vldl.
(12 Dec 1998)
hyperlipoproteinaemia type IV A familial disorder characterised by an isolated elevation in the plasma level of endogenously synthesised triglyceride carried in vldl. It is considered to be an autosomal dominant trait.
(12 Dec 1998)
hyperlipoproteinaemia type v A severe familial adult-onset hypertriglyceridemia different from that due to lipoprotein lipase deficiency.
(12 Dec 1998)
hyperliposis 1. Excessive adiposity.
2. An extreme degree of fatty degeneration.
Origin: hyper-+ G. Lipos, fat
(05 Mar 2000)
hyperlithuria An excessive excretion of uric (lithic) acid in the urine.
(05 Mar 2000)
hyperlogia Morbid verbosity or loquacity.
See: logorrhoea.
Origin: hyper-+ G. Logios, eloquent
(05 Mar 2000)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 17
  • Hyperthyroxinemia, Familial Dysalbuminemic - »õâ An inherited autosomal dominant trait characterized by abnormally elevated levels of total serum THYROXINE; (T4) in euthyroid patients with abnormal SERUM ALBUMIN that binds T4 with enhanced affinity. The serum levels of free T4, free T3, and TSH are normal. It is one of several T4 abnormalities produced by non-thyroid disorder. This condition is due to mutations of the ALB gene on CHROMOSOME 4.
    Synonyms : Familial Dysalbuminemic Hyperthyroxinemia, Dysalbuminemic Hyperthyroxinemia, Familial
  • Hypertonic Solutions - »õâ Solutions that have a greater osmotic pressure than a reference solution such as blood, plasma, or interstitial fluid.
    Synonyms : Solutions, Hypertonic
  • Hypertrichosis - »õâ Excessive hair growth at inappropriate locations, such as on the extremities, the head, and the back. It is caused by genetic or acquired factors, and is an androgen-independent process. This concept does not include HIRSUTISM which is an androgen-dependent excess hair growth in WOMEN and CHILDREN.
    Synonyms : Hypertrichoses
  • Hypertriglyceridemia - »õâ A condition of elevated levels of TRIGLYCERIDES in the blood.
    Synonyms : Hypertriglyceridemias
  • Hypertrophy - »õâ General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
    Synonyms : Hypertrophies
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 5 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 17
hypertrophic pulmonary osteoarthropathy symmetrical osteitis of the four limbs, chiefly localized to the phalanges and the terminal epiphyses of the long bones of the forearm and leg, sometimes extending to the proximal ends of the limbs and the flat bones, and accompanied by a dorsal kyphosis and some affection of the joints. It is often secondary to chronic conditions of the lungs and heart. Called also hyperplastic osteoarthritis, Marie-Bamberger disease or syndrome, pulmonary o., and secondary hypertrophic o.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
hyperosmolar nonketotic coma diabetic coma in which the level of ketone bodies is normal, due to hyperosmolarity of extracellular fluid resulting in dehydration of intracellular fluid; often a consequence of overtreatment with hyperosmolar solutions.
Ãâó: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
hyper- {| border=1 cellspacing=0 style="border-collapse: collapse;"!Prefix !!Meaning ! Examples |-|a(n)- ||not, without ||atonality, asexuality, amoral, anarchyanonymous|-|ab- ||away ||abduction, absolutism, ablution|-|ac- || |||-|acr(o)- ||high, up, hill ||Acropolis|-|aden(o)- || |||-|aer(o)- ||air ||aeronautics, aerodrome, aeroplane, aerodynamics|-|agr(o)- ||relating to farming || agriculture|-|an(a)-||out of||anachronism|-|andr- || man || androgyny, androcentrism, android, androgen|-|anem ...
Ãâó: en.wikipedia.org/wiki/Hyper
hyperkalemic periodic paralysis Hyperkalemic periodic paralysis (HYPP), also known as Impressive Syndrome, is an inherited autosomal dominant disorder which affects sodium channels in muscle cells and the ability to regulate potassium levels in the blood of horses. This inherited disease is characterized by uncontrollable muscle twitching and substantial muscle weakness or paralysis among affected horses. ...
Ãâó: en.wikipedia.org/wiki/Hyperkalemic_Periodic_Paraly...
hyperdontia In dentistry, hyperdontia is the condition of having supernumerary teeth, teeth which appear in addition to the regular number of teeth. The occurrence of hyperdontia ranges from 0.1% to 3.8% in various populations. There is evidence of hereditary factors along with some evidence of environmental factors leading to this condition. Many supernumerary teeth never erupt, but they may delay eruption of nearby teeth or cause other dental problems. Molar-type extra teeth are the rarest form. ...
Ãâó: en.wikipedia.org/wiki/Hyperdontia
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 5 ÆäÀÌÁö: 17
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 17
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 17
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 17
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 17
ÅëÇÕ°Ë»ö ¿Ï·á